43rd Annual Meeting 
of the European Society for 

Blood and Marrow Transplantation
26-29 March 2017 • Marseille, France
SIGN UP FOR UPDATES
REGISTER NOW
  • Home

  • Meeting Information

  • Abstracts

  • Program

  • Registration & Accommodation

  • Media

  • Support & Exhibition

  • More

    Copyright © 2016 EBMT2017.org. All Rights Reserved
    Meeting Organizers
    CME Congresses
    P: +972 3 555 0188
    F: +972 3 540 1566
    ebmt@cme-congresses.com
    Venue 
    Palais des Congrès - Marseille Chanot 
    Parc Chanot, Rond-Point du Prado, 13009 Marseille, France 
    www.marseille-chanot.com
    Contact Information
    Abstracts
    ebmt.abstracts@cme-congresses.com

    Registration & Accommodation 
    ebmt.reg@cme-congresses.com
    Membership
    membership@ebmt.org

    Cell Therapy Day – Monday, March 27th

    All sessions will take place in Room: Les Goudes 2

    ​

    09:00-10:30

    CT1. Cell procurement and processing

    Chairs:                  Riccardo Saccardí, Italy & Sergio Querol, Spain

    09:00-09:30         Practical aspects of G-CSF administration for peripheral blood stem cell collection: Mutlu Arat, Turkey

    09:30-10:00         Management of donor side-effects: Jörg Halter, Switzerland

    10:00-10:30         Full automation of the cryopreservation and thawing of minimally manipulated cell products:
                                  Boris Calmels, France

     

    11:00-12:30

    CT2. Joint ISCT-EBMT Session on substantially manipulated cell products - Manufacturing immune cellular therapies to target malignancies

    Chairs:                  Mark Lowdell, UK & Christian Chabannon, France

    11:00-11:30         Mechanisms of resistance to immune therapies: John Barrett, USA

    11:30-12:00         Improving tumor specific T cells: Catherine Bollard, USA

    12:00-12:30         CAR expressing NK cells: good candidate for “off the shelf ATMP”: Ulrike Köhl, Germany

     

    14:30-16:00

    CT3. Joint ISCT-EBMT Session on substantially manipulated cell products - Part II: Clinical challenges in bringing immune therapies to the clinic

    Chairs:                  Chiara Bonini, Italy & Catherine Bollard, USA

    14:30-14:50         Cell procurement as the first step to manufacture advanced cell therapies: Adrian Gee, USA

    14:50-15:10         Management of complications: He Huang, China

    15:10-15:30         Point of care manufacturing of immune cells: Waseem Qasim, UK

    15:30-16:00         The Joint ISCT-EBMT award for best abstract in cellular therapy

                                  Presented by: Catherine Bollard, USA & Mohamad Mohty, France

                                  Two-pronged Cell Therapy: Engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the
                                  adoptive immunotherapy of B-cell malignancies: Arpad Szoor, USA 

    ​

    16:30-18:00

    CT4. EBMT & European institutions: Working towards the accelerated development of cellular therapies to tackle cancer and other debilitating disorders of the hematopoietic system

    Chairs:                  Jürgen Kuball, Germany & Marcelo Pasquini, USA

    16:30-16:50         European Union support to cell therapy & Horizon 2020: David Gancberg, Belgium

    16:50-17:10         Regulations: Public Health: Stefaan van der Spiegel, Belgium

    17:10-17:30         The EuroGTP II Project – good practices applied to tissues and cells (T&C) preparation processes and patient follow-
                                  up procedures: Esteve Trias Adroher, Spain

    17:30-18:00         Round table: Professional societies facing challenges and opportunities

                                  Chiara Bonini, Italy

                                  Marcelo Pasquini, USA

                                  Jürgen Kuball, Germany